Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose tranexamic acid in adolescent idiopathic scoliosis surgery
ACTRN12617000663358Phase 3Recruiting
- Sponsor
- Associate Professor Dr. Mohd Shahnaz Hasan
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tranexamic acid in adolescent idiopathic scoliosis (AIS), sponsored by Associate Professor Dr. Mohd Shahnaz Hasan. Started Jun 2017; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on ACTRN12617000663358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000663358.